XML 30 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Revenues from Contracts with Customers
3 Months Ended
Mar. 31, 2020
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers

​

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods.

Disaggregation of Revenue

The disaggregation of revenue is based on product category and geographical region. Beginning in the first quarter of 2020, we revised our product categories to more clearly reflect how we sell our products to our customers. We presented historical information under the new revised product categories in a Current Report on Form 8-K, filed with the SEC on April 3, 2020.

We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers for the three-month periods ended March 31, 2020 and 2019 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Three Months Ended

​

​

March 31, 2020

​

March 31, 2019

​

    

United States

    

International

    

Total

    

United States

    

International

    

Total

Cardiovascular

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

 

​

  

Peripheral Intervention

​

$

55,803

​

$

31,272

​

$

87,075

​

$

55,600

​

$

29,033

​

$

84,633

Cardiac Intervention

​

 

28,595

​

​

43,996

​

 

72,591

​

 

27,016

​

 

45,524

​

 

72,540

Custom Procedural Solutions

​

 

25,414

​

​

22,207

​

 

47,621

​

 

23,815

​

 

22,046

​

 

45,861

OEM

​

 

23,666

​

​

4,591

​

 

28,257

​

 

24,061

​

 

3,385

​

 

27,446

Total

​

 

133,478

​

​

102,066

​

 

235,544

​

 

130,492

​

 

99,988

​

 

230,480

​

​

 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Endoscopy

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Endoscopy devices

​

 

7,578

​

 

403

​

 

7,981

​

 

7,568

​

 

301

​

 

7,869

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total

​

$

141,056

​

$

102,469

​

$

243,525

​

$

138,060

​

$

100,289

​

$

238,349

​